NEW YORK, May 4 (GenomeWeb News) - Exiqon today said that IBA, a Goettingen, Germany-based life science tool provider, has licensed its Locked Nucleic Acid (LNA) technology for resale in the genomics research market.

IBA (originally founded as the non-profit Institut f r Bioanalytik) acquired non-exclusive rights to manufacture and sell LNA oligonucleotides.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.